Real-world multicentre study of cefiderocol treatment of immunocompromised patients with infections caused by multidrug-resistant Gram-negative bacteria: CEFI-ID.
Soueges S, Faure E, Parize P, Lanternier-Dessap F, Lecuyer H, Huynh A, Martin-Blondel G, Gaborit B, Blot M, Magallon A, Blanchard E, Brousse X, Lahouati M, Brunel AS, Le Banner E, Camelena F, Larcher R, Pantel A, Melica G, Razazi K, Danion F, Schramm F, Dumitrescu O, Hoellinger B, Ader F; G2I (Groupe Immunodepression et Infections) network.
Soueges S, et al. Among authors: faure e.
J Infect. 2024 Dec 15;90(1):106376. doi: 10.1016/j.jinf.2024.106376. Online ahead of print.
J Infect. 2024.
PMID: 39681233
Free article.